
I Lost 60 Pounds Twice: Once Without a GLP-1, Once With One
GLP Winner's founder lost 60 pounds twice, once on keto and once on a GLP-1. Food noise, side effects, stalls and maintenance, compared honestly.
What is common, what is rare, and when a symptom is worth a call to the prescriber.

GLP Winner's founder lost 60 pounds twice, once on keto and once on a GLP-1. Food noise, side effects, stalls and maintenance, compared honestly.

FDA found mold at one Chinese plant and relabeled raw drug at another, both supplying compounded GLP-1s. See what to ask your pharmacy.

UK officials seized 12,000 fake GLP-1 pens. See where fakes come from, why the US could see more, and how to check the pen in your hand.

Retatrutide isn't approved anywhere, yet it's sold online. See what JAMA found in black market vials and how to spot a safe pharmacy.

A new survey linked GLP-1s to nail lifting. See the real numbers, why experts say it's too early to worry, and what to do if your nails change.

A new Lancet review of 43,000 women found no clear link to birth defects. See who it studied, the one number to watch, and what the labels say.
Some GLP-1 users say they feel flat. Three published cases, what the large trials found, and what to do if it happens to you.

Lawsuits put GLP-1 vision loss back in the news. See the absolute risk, what regulators concluded in 2025, and why the US label differs.

A $95 peptide vial had a brand, a shop and a lab report. See which signals are easy to fake and what a licensed pharmacy is really held to.

A study found 15 cases of a rare B1 deficiency brain injury in GLP-1 users. See what the data shows and the warning sign 13 of them had first.

Do GLP-1s reduce drinking? A 2026 trial says yes for people with obesity, but two trials missed their goal. What the evidence really shows.

GLP-1 medicines slightly raise gallstone and gallbladder risk from fast weight loss. See how common it is, how to lower risk, and warning signs.
